A randomised placebo-controlled trial of a traditional Chinese herbal formula in the treatment of primary dysmenorrhoea.
BACKGROUND
Most traditional Chinese herbal formulas consist of at least four herbs. Four-Agents-Decoction (Si Wu Tang) is a documented eight hundred year old formula containing four herbs and has been widely used to relieve menstrual discomfort in Taiwan. However, no specific effect had been systematically evaluated. We applied Western methodology to assess its effectiveness and safety for primary dysmenorrhoea and to evaluate the compliance and feasibility for a future trial.


RESULTS
A randomised, double-blind, placebo-controlled, pilot clinical trial was conducted in an ad hoc clinic setting at a teaching hospital in Taipei, Taiwan. Seventy-eight primary dysmenorrheic young women were enrolled after 326 women with self-reported menstrual discomfort in the Taipei metropolitan area of Taiwan were screened by a questionnaire and subsequently diagnosed by two gynaecologists concurrently with pelvic ultrasonography. A dosage of 15 odorless capsules daily for five days starting from the onset of bleeding or pain was administered. Participants were followed with two to four cycles for an initial washout interval, one to two baseline cycles, three to four treatment cycles, and three follow-up cycles. Study outcome was pain intensity measured by using unmarked horizontal visual analog pain scale in an online daily diary submitted directly by the participants for 5 days starting from the onset of bleeding or pain of each menstrual cycle. Overall-pain was the average pain intensity among days in pain and peak-pain was the maximal single-day pain intensity. At the end of treatment, both the overall-pain and peak-pain decreased in the Four-Agents-Decoction (Si Wu Tang) group and increased in the placebo group; however, the differences between the two groups were not statistically significant. The trends persisted to follow-up phase. Statistically significant differences in both peak-pain and overall-pain appeared in the first follow-up cycle, at which the reduced peak-pain in the Four-Agents-Decoction (Si Wu Tang) group did not differ significantly by treatment length. However, the reduced peak-pain did differ profoundly among women treated for four menstrual cycles (2.69 (2.06) cm, mean (standard deviation), for the 20 women with Four-Agents-Decoction and 4.68 (3.16) for the 22 women with placebo, p = .020.) There was no difference in adverse symptoms between the Four-Agents-Decoction (Si Wu Tang) and placebo groups.


CONCLUSIONS
Four-Agents-Decoction (Si Wu Tang) therapy in this pilot post-market clinical trial, while meeting the standards of conventional medicine, showed no statistically significant difference in reducing menstrual pain intensity of primary dysmenorrhoea at the end of treatment. Its use, with our dosage regimen and treatment length, was not associated with adverse reactions. The finding of statistically significant pain-reducing effect in the first follow-up cycle was unexpected and warrants further study. A larger similar trial among primary dysmenorrheic young women with longer treatment phase and multiple batched study products can determine the definitive efficacy of this historically documented formula.


BACKGROUND
Controlled-Trials.com ISRCTN23374750.
Yeh
Lan Lan Liang
LL
Division of Clinical Research, National Health Research Institutes, Zhunan, Taiwan. lanlanliang2@yahoo.com
Liu
Jah-Yao
JY
Lin
Kao-Si
KS
Liu
Yu-Shen
YS
Chiou
Jeng-Min
JM
Liang
Kung-Yee
KY
Tsai
Te-Feng
TF
Wang
Li-Hsiang
LH
Chen
Chiung-Tong
CT
Huang
Ching-Yi
CY
D000328:Adult; D000700:Analgesics / Q000627:therapeutic use*; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D004412:Dysmenorrhea / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008516:Medicine, Chinese Traditional; D010147:Pain Measurement; D010865:Pilot Projects; D010919:Placebos / Q000627:therapeutic use*; D011247:Pregnancy; D011795:Surveys and Questionnaires; D013624:Taiwan; D055815:Young Adult
D000700:Analgesics; D004365:Drugs, Chinese Herbal; D010919:Placebos
Acta Obstet Gynecol Scand. 2000 Dec;79(12):1112-6
11130097
Occup Environ Med. 2004 Dec;61(12):1021-6
15550609
BJOG. 2001 Nov;108(11):1181-3
11762659
Clin Ther. 2002 Sep;24(9):1384-400
12380631
N Engl J Med. 2002 Dec 19;347(25):2046-56
12490687
Am J Epidemiol. 2003 Feb 15;157(4):364-75
12578807
Eur J Obstet Gynecol Reprod Biol. 2003 Apr 25;107(2):191-4
12648867
Cochrane Database Syst Rev. 2003;(4):CD001751
14583938
J Pain. 2003 Sep;4(7):407-14
14622683
Pediatrics. 1981 Nov;68(5):661-4
7312467
J Reprod Med. 2005 Apr;50(4):251-5
15916208
Fertil Steril. 2006 Sep;86(3):762-4
16784743
Am J Obstet Gynecol. 1982 Nov 15;144(6):655-60
7137249
Am J Obstet Gynecol. 1992 Feb;166(2):578-83
1536234
Ann Acad Med Singapore. 1992 May;21(3):323-7
1416778
Ann Emerg Med. 1996 Apr;27(4):485-9
8604867
Br J Obstet Gynaecol. 1996 Nov;103(11):1134-42
8917003
Pediatr Allergy Immunol. 1996 Aug;7(3):130-40
9116877
Am J Chin Med. 1997;25(2):205-12
9288368
Br J Obstet Gynaecol. 1998 Jan;105(1):93-9
9442169
JAMA. 1998 Nov 11;280(18):1585-9
9820260
Fertil Steril. 1998 Dec;70(6):1101-8
9848302
Ginecol Obstet Mex. 1998 Dec;66:492-4
9951177
J Adolesc Health. 1999 Jul;25(1):40-5
10418884
Am Fam Physician. 1999 Aug;60(2):489-96
10465224
Cochrane Database Syst Rev. 2001;(4):CD002120
11687142